1936-5233

Translational Oncology

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 3179 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact3179 DOIs
2

Attach ORCID iDs across 1812 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1812 DOIs
3

Deposit reference lists for 64 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact64 DOIs

DOIs for this ISSN

Showing the top 5 of 3179 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Global colorectal cancer burden in 2020 and projections to 2… (10.1016/j.tranon.2021.101174)
Abstract ORCID
166.79 2166
2 Epithelial-Mesenchymal Transition in Cancer: A Historical Ov… (10.1016/j.tranon.2020.100773)
Abstract ORCID
146.93 867
3 PLK1, A Potential Target for Cancer Therapy (10.1016/j.tranon.2016.10.003)
Abstract ORCID
130.69 410
4 SPARC Expression Correlates with Tumor Response to Albumin-B… (10.1593/tlo.09109)
Abstract ORCID
126.64 340
5 Resistance to Checkpoint Inhibition in Cancer Immunotherapy (10.1016/j.tranon.2019.12.010)
Abstract ORCID
120.58 257
6 Reproducibility and Prognosis of Quantitative Features Extra… (10.1593/tlo.13844)
Abstract ORCID
120.41 255
7 Modeling Adult Gliomas Using RCAS/t-va Technology (10.1593/tlo.09100)
Abstract ORCID
119.90 249
8 A Comprehensive Immunologic Portrait of Triple-Negative Brea… (10.1016/j.tranon.2018.01.011)
Abstract ORCID
118.18 230
9 Fusobacterium nucleatum Contributes to the Carcinogenesis of… (10.1016/j.tranon.2019.03.003)
Abstract ORCID
118.18 230
10 Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic… (10.1593/tlo.09256)
Abstract ORCID
118.09 229
11 A Systemic Complete Response of Metastatic Melanoma to Local… (10.1593/tlo.12280)
Abstract ORCID
115.80 206
12 Plasticity of cancer cell invasion: Patterns and mechanisms (10.1016/j.tranon.2020.100899)
Abstract ORCID
115.69 205
13 Ionizing Radiation and Glioblastoma Exosomes: Implications i… (10.1593/tlo.13640)
Abstract ORCID
115.37 202
14 Targeting p53 for Novel Anticancer Therapy (10.1593/tlo.09250)
Abstract ORCID
115.27 201
15 Elimination of Colon Cancer Stem-Like Cells by the Combinati… (10.1593/tlo.09193)
Abstract ORCID
114.28 192
16 Hypoxia, partial EMT and collective migration: Emerging culp… (10.1016/j.tranon.2020.100845)
Abstract ORCID
114.17 191
17 Mutational Analysis of Circulating Tumor Cells Using a Novel… (10.1593/tlo.13367)
Abstract ORCID
113.36 184
18 Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathol… (10.1016/j.tranon.2017.12.012)
Abstract ORCID
113.12 182
19 HDAC inhibitors: Targets for tumor therapy, immune modulatio… (10.1016/j.tranon.2021.101312)
Abstract ORCID
110.87 164
20 Preoperative C-Reactive Protein/Albumin Ratio Predicts Progn… (10.1016/j.tranon.2015.06.006)
Abstract ORCID
110.74 163
21 Targeting Polo-Like Kinases: A Promising Therapeutic Approac… (10.1016/j.tranon.2015.03.010)
Abstract ORCID
108.95 150
22 m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways… (10.1016/j.tranon.2019.06.007)
Abstract ORCID
108.80 149
23 Angiogenesis and Antiangiogenesis in Triple-Negative Breast… (10.1016/j.tranon.2016.07.002)
Abstract ORCID
108.66 148
24 A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Me… (10.1016/j.tranon.2017.07.008)
Abstract ORCID
107.77 142
25 Ecological Therapy for Cancer: Defining Tumors Using an Ecos… (10.1593/tlo.08178)
Abstract ORCID
107.61 141
26 2D and 3D CT Radiomics Features Prognostic Performance Compa… (10.1016/j.tranon.2017.08.007)
Abstract ORCID
106.68 135
27 Circulating Cell-Free DNA from Colorectal Cancer Patients Ma… (10.1593/tlo.12445)
Abstract ORCID
106.19 132
28 A Feasibility Study of Parametric Response Map Analysis of D… (10.1593/tlo.09175)
Abstract ORCID
106.03 131
29 Applications of the Repeatability of Quantitative Imaging Bi… (10.1593/tlo.09268)
Abstract ORCID
106.03 131
30 Early Prediction and Evaluation of Breast Cancer Response to… (10.1016/j.tranon.2015.11.016)
Abstract ORCID
105.02 125
31 Targeting Tumor Microenvironment by Small-Molecule Inhibitor… (10.1016/j.tranon.2019.10.001)
Abstract ORCID
105.02 125
32 Antidiabetic Drug Metformin Prevents Progression of Pancreat… (10.1593/tlo.13556)
Abstract ORCID
104.67 123
33 Vascular Mimicry: A Novel Neovascularization Mechanism Drivi… (10.1016/j.tranon.2017.04.007)
Abstract ORCID
104.50 122
34 The interaction mechanism between autophagy and apoptosis in… (10.1016/j.tranon.2020.100871)
Abstract ORCID
104.50 122
35 A Phase Ib Study of Pembrolizumab as Second-Line Therapy for… (10.1016/j.tranon.2019.02.007)
Abstract ORCID
104.32 121
36 Biomarker Discovery in Human Prostate Cancer: an Update in M… (10.1016/j.tranon.2016.05.004)
Abstract ORCID
104.14 120
37 Variations of Dynamic Contrast-Enhanced Magnetic Resonance I… (10.1593/tlo.13838)
Abstract ORCID
104.14 120
38 Combined Resveratrol, Quercetin, and Catechin Treatment Redu… (10.1593/tlo.07100)
Abstract ORCID
103.59 117
39 Limitations of Anti-Angiogenic Treatment of Tumors (10.1016/j.tranon.2019.04.022)
Abstract ORCID
103.41 116
40 Transferrin Receptor 2 Is Frequently and Highly Expressed in… (10.1593/tlo.09274)
Abstract ORCID
103.41 116
41 Human Lymphatic Architecture and Dynamic Transport Imaged Us… (10.1593/tlo.10190)
Abstract ORCID
103.03 114
42 Immunogenomics Analysis Reveals that TP53 Mutations Inhibit… (10.1016/j.tranon.2018.07.012)
Abstract ORCID
102.85 113
43 Exploring Variability in CT Characterization of Tumors: A Pr… (10.1593/tlo.13865)
Abstract ORCID
102.46 111
44 Biomarker Development for the Clinical Activity of the mTOR… (10.1593/tlo.09277)
Abstract ORCID
102.27 110
45 A CRISPR Test for Detection of Circulating Nuclei Acids (10.1016/j.tranon.2019.08.011)
Abstract ORCID
101.87 108
46 Diffusion-Weighted Imaging in Meningioma: Prediction of Tumo… (10.1016/j.tranon.2015.11.012)
Abstract ORCID
101.47 106
47 Variability of Image Features Computed from Conventional and… (10.1016/j.tranon.2015.11.013)
Abstract ORCID
101.27 105
48 Tumor-associated neutrophils suppress antitumor immunity of… (10.1016/j.tranon.2020.100825)
Abstract ORCID
101.27 105
49 Etoposide, an anticancer drug involved in therapy-related se… (10.1016/j.tranon.2021.101169)
Abstract ORCID
101.27 105
50 Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positi… (10.1593/tlo.13256)
Abstract ORCID
101.06 104